Option Care Health (NASDAQ:OPCH – Free Report) had its price objective lifted by Barrington Research from $32.00 to $33.00 in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.
OPCH has been the subject of several other research reports. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $26.00 to $33.00 in a research note on Monday. UBS Group started coverage on shares of Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Finally, Truist Financial cut their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $29.86.
Read Our Latest Research Report on OPCH
Option Care Health Stock Up 3.6 %
Insider Buying and Selling
In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the stock in a transaction on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by corporate insiders.
Institutional Trading of Option Care Health
Hedge funds have recently added to or reduced their stakes in the company. Westfield Capital Management Co. LP increased its holdings in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. increased its stake in shares of Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after purchasing an additional 25,905 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the period. Graypoint LLC purchased a new position in Option Care Health during the fourth quarter worth approximately $1,161,000. Finally, Edgestream Partners L.P. grew its holdings in Option Care Health by 96.8% in the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock valued at $9,736,000 after purchasing an additional 172,845 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- When to Sell a Stock for Profit or Loss
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Energy and Oil Stocks Explained
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Retail Stocks Investing, Explained
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.